Importance of communication between producers and consumers of publicly available experimental data

Journal of the National Cancer Institute

Volumn 97, Issue 4, 2005, Pages 310-314

  Liotta, Lance A ^a   Lowenthal, Mark ^a   Mehta, Arpita ^a   Conrads, Thomas P ^b   Veenstra, Timothy D ^b   Fishman, David A ^c   Petricoin III, Emanuel F ^d  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b SAIC FREDERICK INC   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CARRIER PROTEIN; PROTEIN; PROTEOME; TUMOR MARKER;

ANALYTICAL ERROR; ARTICLE; CONSUMER; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERPERSONAL COMMUNICATION; LABORATORY TEST; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OVARY CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEOMICS; REPRODUCIBILITY; STANDARDIZATION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION PROCESS; BLOOD; DNA FINGERPRINTING; LABORATORY; NEOPLASM; PUBLIC RELATIONS; STANDARD;

COMMUNICATION; DNA FINGERPRINTING; HUMANS; INTERPROFESSIONAL RELATIONS; LABORATORIES; MASS SPECTROMETRY; NEOPLASMS; PROTEOME; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 13844315666     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/dji053     Document Type: Article

References (24)

1. Baggerly KA, Morris JS, Edmonson SR, Coombes KR. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J Natl Cancer Inst 2005;97:307-9.
2. Zhu W, Wang X, Ma Y, Rao M, Glimm J, Kovach JS. Detection of cancer-specific markers amid massive mass spectral data. Proc Natl Acad Sci U S A 2003;100:14666-71.
3. Petricoin EF, Fishman' DA, Conrads TP, Veenstra TD, Liotta LA. Proteomic pattern diagnostics: producers and consumers in the era of correlative science. Available at: http://www.biomedcentral.com/1471-2105/4/24/comments. [Last accessed: January 15, 2005.]
4. Petricoin EF, Fishman DA, Conrads TP, Veenstra TD, Liotta LA. Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics. Proteomics 2004;4:2357-60.
5. Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campus D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin A, Prasanna P, Rosenzweig J, Sokoll LJ, Srivastava S, Thompson I, Welsh MJ, White N, Winget M, Yasui Y, Zhang Z, Zhu L. Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility. Clin Chem. 2005 Jan;51(1):102-12.
6. Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 2004;64:5882-90.
7. Paweletz CP, Gillespie JW, Ornstein DK, Simone NL, Brown MR, Cole KA, et al. Biomarker profiling of stages of cancer progression directly from human tissue using a protein biochip. Drug Dev Res 2000;49:34-42.
8. Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 2001;7:493-6.
9. Goodacre R, Neal MJ, Kell DB, Greenham LW, Noble WC, Harvey RG. Rapid identification using pyrolysis mass spectrometry and artificial neural networks of Propionibacterium acnes isolated from dogs. J Appl Bacteriol 1994;76:124-34.
10. Holland RD, Wilkes JG, Rafii F, Sutherland JB, Persons CC, Voorhees KJ, Lay JO Jr. Rapid identification of intact whole bacteria based on spectral patterns using matrix-assisted laser desorption/ionization with time-of-flight mass spectrometry. Rapid Commun Mass Spectrum 1996;10: 1227-32.
11. Petricoin EF III, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002;94:1576-8.
12. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7.
13. Ornstein DK, Rayford W, Fusaro VA, Conrads TP, Ross SJ, Hitt BA, et al. Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. J Urol 2004;172:1302-5.
14. Wadsworth JT, Somers KD, Cazares LH, Malik G, Adam BL, Stack BC Jr, et al. Serum protein profiles to identify head and neck cancer. Clin Cancer Res 2004;10:1625-32.
15. Vlahou A, Laronga C, Wilson L, Gregory B, Fournier K, McGaughey D, et al. A novel approach toward development of a rapid blood test for breast cancer. Clin Breast Cancer 2003;4:203-9.
16. Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, Holland EC, Tempst P. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 2004;76:1560-70.
17. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003;4:437-50.
18. Conrads TP, Fusaro VA, Ross S, Johann D, Rajapakse V, Hitt BA, et al. High-resolution serum proteomic features for ovarian cancer detection. Endocr Relat Cancer 2004;11:163-78.
19. Malyarenko DI, Cooke WE, Adam BL, Malik G, Chen H, Tracy ER, et al. Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques. Clin Chem 2005;51: 65-74.
20. Koopmann J, Zhang Z, White N, Rosenzweig J, Fedarko N, Jagannath S, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 2004;10:860-8.
21. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48:1296-304.
22. Liotta LA, Ferrari M, Petricoin E. Clinical proteomics: written in blood. Nature 2003;425:905.
23. Mehta AI, Ross S, Lowenthal MS, Fusaro V, Fishman DA, Petricoin EF III, Liotta LA. Biomarker amplification by serum carrier protein binding. Dis Markers 2003-2004;19:1-10.
24. Zhou M, Lucas DA, Chan K, Issaq HJ, Petricoin EF III, Liotta LA, et al. Investigation into the human serum interactome. Electrophoresis 2004;25:1289-98.